Drug Manufacturers - General

The Drug Manufacturers - General industry has a total of 19 stocks, with a combined market cap of $3,061.35 billion, total revenue of $676.65 billion and a weighted average PE ratio of 33.55.

Market Cap
3,061.35B
Revenue
676.65B
Profits
91.25B
PE Ratio
33.55
Profit Margin
13.49%
Dividend Yield
2.35%

19 Stocks

No. Symbol Company Name Market Cap % Change Volume Revenue
1LLYEli Lilly and Company653.46B-4.21%4,870,23940.86B
2JNJJohnson & Johnson353.99B-0.50%7,405,87987.70B
3NVONovo Nordisk A/S341.33B-5.27%19,516,71340.47B
4ABBVAbbVie Inc.303.17B-1.23%6,724,54655.53B
5MRKMerck & Co., Inc.247.70B-2.76%10,700,54463.17B
6AZNAstraZeneca PLC205.86B-0.46%5,108,93351.21B
7NVSNovartis AG195.35B-0.34%1,346,12449.94B
8PFEPfizer Inc.149.04B-0.72%27,472,45059.38B
9AMGNAmgen Inc.146.27B0.99%3,220,30332.53B
10SNYSanofi128.27B-2,420,44454.03B
11GILDGilead Sciences, Inc.114.46B0.21%6,838,10728.30B
12BMYBristol-Myers Squibb Company114.17B-0.16%9,317,88347.44B
13GSKGSK plc67.61B-0.03%3,406,61741.97B
14BIIBBiogen Inc.20.48B-0.48%1,056,7119.61B
15GRFSGrifols, S.A.5.73B0.41%374,0047.81B
16OGNOrganon & Co.4.05B-2.72%2,527,4176.41B
17AMRNAmarin Corporation plc229.53M0.72%633,585241.02M
18SCLXScilex Holding Company82.28M-4.31%1,175,88255.15M
19MIRAMIRA Pharmaceuticals, Inc.20.04M0.83%181,839-